Chris A Rallis - Net Worth and Insider Trading
Chris A Rallis Net Worth
The estimated net worth of Chris A Rallis is at least $324,771 dollars as of 2024-12-28. Chris A Rallis is the Director of Fennec Pharmaceuticals Inc and owns about 52,214 shares of Fennec Pharmaceuticals Inc (FENC) stock worth over $324,771. Details can be seen in Chris A Rallis's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Chris A Rallis has not made any transactions after 2024-12-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Chris A Rallis
Chris A Rallis Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Chris A Rallis owns 3 companies in total, including Fennec Pharmaceuticals Inc (FENC) , Tenax Therapeutics Inc (TENX) , and Aeolus Pharmaceuticals Inc (AOLS) .
Click here to see the complete history of Chris A Rallis’s form 4 insider trades.
Insider Ownership Summary of Chris A Rallis
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FENC | Fennec Pharmaceuticals Inc | 2024-12-02 | director |
| TENX | Tenax Therapeutics Inc | 2013-07-23 | director |
| AOLS | Aeolus Pharmaceuticals Inc | 2013-10-01 | director |
Chris A Rallis Latest Holdings Summary
Chris A Rallis currently owns a total of 1 stock. Chris A Rallis owns 52,214 shares of Fennec Pharmaceuticals Inc (FENC) as of December 2, 2024, with a value of $324,771.
Latest Holdings of Chris A Rallis
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FENC | Fennec Pharmaceuticals Inc | 2024-12-02 | 52,214 | 6.22 | 324,771 |
Holding Weightings of Chris A Rallis
Chris A Rallis Form 4 Trading Tracker
According to the SEC Form 4 filings, Chris A Rallis has made a total of 12 transactions in Fennec Pharmaceuticals Inc (FENC) over the past 5 years, including 0 buys and 12 sells. The most-recent trade in Fennec Pharmaceuticals Inc is the sale of 6,409 shares on December 2, 2024, which brought Chris A Rallis around $39,351.
Insider Trading History of Chris A Rallis
- 1
Chris A Rallis Trading Performance
Chris A Rallis Ownership Network
Chris A Rallis Owned Company Details
What does Fennec Pharmaceuticals Inc do?
Who are the key executives at Fennec Pharmaceuticals Inc?
Chris A Rallis is the director of Fennec Pharmaceuticals Inc. Other key executives at Fennec Pharmaceuticals Inc include director & Chief Executive Officer Rosty Raykov , Chief Financial Officer Robert Andrade , and Chief Commercial Officer Shubh Goel .
Fennec Pharmaceuticals Inc (FENC) Insider Trades Summary
Over the past 18 months, Chris A Rallis made 10 insider transaction in Fennec Pharmaceuticals Inc (FENC) with a net sale of 23,237. Other recent insider transactions involving Fennec Pharmaceuticals Inc (FENC) include a net sale of 177,315 shares made by Rosty Raykov , a net sale of 82,950 shares made by Robert Andrade , and a net sale of 222,221 shares made by Adrian Haigh .
In summary, during the past 3 months, insiders sold 15,108 shares of Fennec Pharmaceuticals Inc (FENC) in total and bought 0 shares, with a net sale of 15,108 shares. During the past 18 months, 505,723 shares of Fennec Pharmaceuticals Inc (FENC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 505,723 shares.
Fennec Pharmaceuticals Inc (FENC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fennec Pharmaceuticals Inc Insider Transactions
Chris A Rallis Mailing Address
Above is the net worth, insider trading, and ownership report for Chris A Rallis. You might contact Chris A Rallis via mailing address: C/o Tenax Therapeutics, Inc., One Copley Parkway, Suite 490, Morrisville Nc 27560.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
